Report cover image

Latin America In-vitro Colorectal Cancer Screening Tests Market Report and Forecast 2024-2032

Publisher Expert Market Research
Published Jun 26, 2024
Length 140 Pages
SKU # EMAR18971406

Description

Latin America In-vitro Colorectal Cancer Screening Tests Market Report and Forecast 2024-2032


Latin America In-vitro Colorectal Cancer Screening Tests Market Report and Forecast 2024-2032

Latin America In-vitro Colorectal Cancer Screening Tests Market Size

The global in-vitro colorectal cancer screening tests market was valued at USD 920.4 million in 2023, with Latin America holding a significant market share. The market is driven by the growing demand for non-invasive or minimally invasive colorectal cancer screening methods. It is expected to grow at a CAGR of 5.53% during the forecast period of 2024-2032, with the values likely to attain USD 1492.8 million by 2032.

Latin America In-vitro Colorectal Cancer Screening Tests Market Outlook
  • The market share is influenced by the growing preference for non-invasive colorectal cancer screening methods such as fecal immunochemical tests (FIT) and DNA-based tests.
  • In October 2023, the Pan American Health Organization (PAHO) and the International Agency for Research on Cancer (IARC) jointly launched the Latin American and the Caribbean Code against Cancer to develop recommendations for cancer prevention in the region. Such initiatives are likely to increase screening rates, which is expected to elevate the Latin America in-vitro colorectal cancer screening tests market value in the forecast period.
  • In Brazil, colorectal cancer stands as the second most frequent cancer in men and women, with the mortality rate estimated to reach 9.4% of those diagnosed. The rising burden of colorectal cancer is poised to augment the market demand for in-vitro screening tests.
Latin America In-vitro Colorectal Cancer Screening Tests Market Analysis

In-vitro colorectal cancer screening tests are designed to detect abnormalities such as blood in stool, genetic mutations, or other biomarkers associated to colorectal cancer. They can identify individuals at a high risk of colorectal cancer and thus play an integral role in early detection and prevention efforts. The increasing use of these diagnostic tests can be attributed to the non-invasive or minimally invasive nature is expected to fuel their adoption rates and drive the Latin America in-vitro colorectal cancer screening tests market growth.

Recent data suggests that deaths due to colorectal cancer are rising in Latin American countries. In Brazil, colorectal cancer stands as the second most frequent cancer in men and women, with the mortality rate estimated to reach 9.4% of those diagnosed. This indicates the growing need for effective screening tests, intended to detect this cancer at an early stage when the interventions are most likely to be successful. Thus, the rising burden of colorectal cancer coupled with the increasing aging population, is poised to augment the market demand for these diagnostic tests.

One of the major Latin America in-vitro colorectal cancer screening tests market trends is the increased initiatives and awareness campaigns to promote cancer screening and reduce cancer mortality rates. In October 2023, the Pan American Health Organization (PAHO) and the International Agency for Research on Cancer (IARC) collaborated to launch the Latin American and the Caribbean Code against Cancer to develop recommendations for cancer prevention in the region. They released 17 actions to help prevent cancer including the need for early detection tests of colorectal cancer for people aged between 50 and 74 . Such collaborative measures are likely to increase awareness among the public, leading to higher screening rates and greater adoption of in-vitro screening tests, and ultimately propelling the market growth.

Latin America In-vitro Colorectal Cancer Screening Tests Market Segmentation  

The report offers a detailed analysis of the market based on the following segments:

Market Breakup by Testing Type

Fecal Occult Blood Tests

Biomarker Tests

CRC DNA Screening Tests

Flexible Sigmoidoscopy

Others

Market Breakup by Imaging Type

Colonoscopy

Proctoscopy

CT Scan

Ultrasound

MRI

PET Scan

Market Breakup by End User

Hospitals

Clinics

Diagnostics Laboratories

Market Breakup by Country

Brazil

Argentina

Mexico

Others

Leading Players in the Latin America In-vitro Colorectal Cancer Screening Tests Market

The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Beckman Coulter Inc.
  • Abbott
  • Siemens Healthineers International AG
  • Quest Diagnostics
  • Oncocyte Corporation
  • Merck KGaA
  • Randox Laboratories Ltd.
  • R-Biopharm AG
  • Sysmex Corporation
  • Medline Industries LP
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

FAQs
  • What is the Latin America in-vitro colorectal cancer screening tests market forecast outlook for 2024-2032?
The Latin America in-vitro colorectal cancer screening tests market is expected to be driven by the rising demand for the global market, which is anticipated to grow at a CAGR of 5.53% during the forecast period of 2024-2032 and is likely to reach a market value of USD 1492.8 million by 2032.
  • What are the major factors aiding the Latin America in-vitro colorectal cancer screening tests market demand?
The rising prevalence of colorectal cancer and advancements in screening technology are fuelling the demand for the market.
  • What are the major Latin America in-vitro colorectal cancer screening tests market trends?
One of the significant market trends is the increased initiatives and awareness campaigns to promote cancer screening. In October 2023, the Pan American Health Organization (PAHO) and the International Agency for Research on Cancer (IARC) jointly launched the Latin American and the Caribbean Code against Cancer to develop recommendations for cancer prevention in the region.
  • What is the market segmentation based on the testing type?
Based on the testing type, the market is segmented into fecal occult blood tests, biomarker tests, CRC DNA screening tests, and flexible sigmoidoscopy, among others.
  • What is the market breakup by imaging type?
By imaging type, the market is divided into colonoscopy, proctoscopy, CT scan, ultrasound, MRI, and PET scan.
  • What are the major end users of the market?
End users of the market are hospitals, clinics, and diagnostic laboratories.
  • What is the market segmentation by countries?
The market segmentation by countries includes Brazil, Argentina, and Mexico, among others.
  • Who are the key players involved in the Latin America in-vitro colorectal cancer screening tests market?
The key players in the market are Beckman Coulter Inc., Abbott, Siemens Healthineers International AG, Quest Diagnostics, Oncocyte Corporation, Merck KGaA, Randox Laboratories Ltd., R-Biopharm AG, Sysmex Corporation, and Medline Industries LP.

Meta description

The Latin America in-vitro colorectal cancer screening tests market is poised for growth, driven by the expansion of the global market, which was valued at USD 920.4 million in 2023 and is projected to grow at a CAGR of 5.53% during the forecast period of 2024-2032.

*Please Note:* The report will take 7 business days to complete, after order confirmation.

Table of Contents

140 Pages
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Latin America In-vitro Colorectal Cancer Screening Tests Market Overview
3.1 Latin America In-vitro Colorectal Cancer Screening Tests Market Historical Value (2017-2023)
3.2 Latin America In-vitro Colorectal Cancer Screening Tests Market Forecast Value (2024-2032)
4 Latin America In-vitro Colorectal Cancer Screening Tests Market Landscape*
4.1 Latin America In-vitro Colorectal Cancer Screening Tests: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Latin America In-vitro Colorectal Cancer Screening Tests: Product Landscape
4.2.1 Analysis by Test Type
4.2.2 Analysis by Imaging Type
5 Latin America In-vitro Colorectal Cancer Screening Tests Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Latin America In-vitro Colorectal Cancer Screening Tests Market Segmentation (2017-2032)
6.1 Latin America In-vitro Colorectal Cancer Screening Tests Market (2017-2032) by Testing Type
6.1.1 Market Overview
6.1.2 Fecal Occult Blood Tests
6.1.3 Biomarker Tests
6.1.4 CRC DNA Screening Tests
6.1.5 Flexible Sigmoidoscopy
6.1.6 Others
6.2 Latin America In-vitro Colorectal Cancer Screening Tests Market (2017-2032) by Imaging Type
6.2.1 Market Overview
6.2.2 Colonoscopy
6.2.3 Proctoscopy
6.2.4 CT Scan
6.2.5 Ultrasound
6.2.6 MRI
6.2.7 PET Scan
6.3 Latin America In-vitro Colorectal Cancer Screening Tests Market (2017-2032) by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Clinics
6.3.4 Diagnostic Laboratories
6.4 Latin America In-vitro Colorectal Cancer Screening Tests Market (2017-2032) by Country
6.4.1 Market Overview
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Others
7 Brazil In-vitro Colorectal Cancer Screening Tests Market (2017-2032)
7.1 Brazil In-vitro Colorectal Cancer Screening Tests Market (2017-2032) by Testing Type
7.1.1 Market Overview
7.1.2 Fecal Occult Blood Tests
7.1.3 Biomarker Tests
7.1.4 CRC DNA Screening Tests
7.1.5 Flexible Sigmoidoscopy
7.1.6 Others
7.2 Brazil In-vitro Colorectal Cancer Screening Tests Market (2017-2032) by Imaging Type
7.2.1 Market Overview
7.2.2 Colonoscopy
7.2.3 Proctoscopy
7.2.4 CT Scan
7.2.5 Ultrasound
7.2.6 MRI
7.2.7 PET Scan
7.3 Brazil In-vitro Colorectal Cancer Screening Tests Market (2017-2032) by End User
7.3.1 Market Overview
7.3.2 Hospitals
7.3.3 Clinics
7.3.4 Diagnostics Laboratories
8 Argentina In-vitro Colorectal Cancer Screening Tests Market (2017-2032)
8.1 Argentina In-vitro Colorectal Cancer Screening Tests Market (2017-2032) by Testing Type
8.1.1 Market Overview
8.1.2 Fecal Occult Blood Tests
8.1.3 Biomarker Tests
8.1.4 CRC DNA Screening Tests
8.1.5 Flexible Sigmoidoscopy
8.1.6 Others
8.2 Argentina In-vitro Colorectal Cancer Screening Tests Market (2017-2032) by Imaging Type
8.2.1 Market Overview
8.2.2 Colonoscopy
8.2.3 Proctoscopy
8.2.4 CT Scan
8.2.5 Ultrasound
8.2.6 MRI
8.2.7 PET Scan
8.3 Argentina In-vitro Colorectal Cancer Screening Tests Market (2017-2032) by End User
8.3.1 Market Overview
8.3.2 Hospitals
8.3.3 Clinics
8.3.4 Diagnostics Laboratories
9 Mexico In-vitro Colorectal Cancer Screening Tests Market (2017-2032)
9.1 Mexico In-vitro Colorectal Cancer Screening Tests Market (2017-2032) by Testing Type
9.1.1 Market Overview
9.1.2 Fecal Occult Blood Tests
9.1.3 Biomarker Tests
9.1.4 CRC DNA Screening Tests
9.1.5 Flexible Sigmoidoscopy
9.1.6 Others
9.2 Mexico In-vitro Colorectal Cancer Screening Tests Market (2017-2032) by Imaging Type
9.2.1 Market Overview
9.2.2 Colonoscopy
9.2.3 Proctoscopy
9.2.4 CT Scan
9.2.5 Ultrasound
9.2.6 MRI
9.2.7 PET Scan
9.3 Mexico In-vitro Colorectal Cancer Screening Tests Market (2017-2032) by End User
9.3.1 Market Overview
9.3.2 Hospitals
9.3.3 Clinics
9.3.4 Diagnostics Laboratories
10 Regulatory Framework
11 Patent Analysis
11.1 Analysis by Type of Patent
11.2 Analysis by Publication Year
11.3 Analysis by Issuing Authority
11.4 Analysis by Patent Age
11.5 Analysis by CPC Analysis
11.6 Analysis by Patent Valuation
11.7 Analysis by Key Players
12 Grants Analysis
12.1 Analysis by Year
12.2 Analysis by Amount Awarded
12.3 Analysis by Issuing Authority
12.4 Analysis by Grant Application
12.5 Analysis by Funding Institute
12.6 Analysis by Departments
12.7 Analysis by Recipient Organization
13 Partnership and Collaborations Analysis
13.1 Analysis by Partnership Instances
13.2 Analysis by Type of Partnership
13.3 Analysis by Leading Players
13.4 Analysis by Geography
14 Supplier Landscape
14.1 Market Share by Top 5 Companies
14.2 Beckman Coulter Inc.
14.2.1 Financial Analysis
14.2.2 Product Portfolio
14.2.3 Demographic Reach and Achievements
14.2.4 Mergers and Acquisitions
14.2.5 Certifications
14.3 Abbott
14.3.1 Financial Analysis
14.3.2 Product Portfolio
14.3.3 Demographic Reach and Achievements
14.3.4 Mergers and Acquisitions
14.3.5 Certifications
14.4 Siemens Healthineers International AG
14.4.1 Financial Analysis
14.4.2 Product Portfolio
14.4.3 Demographic Reach and Achievements
14.4.4 Mergers and Acquisitions
14.4.5 Certifications
14.5 Quest Diagnostics
14.5.1 Financial Analysis
14.5.2 Product Portfolio
14.5.3 Demographic Reach and Achievements
14.5.4 Mergers and Acquisitions
14.5.5 Certifications
14.6 Oncocyte Corporation
14.6.1 Financial Analysis
14.6.2 Product Portfolio
14.6.3 Demographic Reach and Achievements
14.6.4 Mergers and Acquisitions
14.6.5 Certifications
14.7 Merck KGaA
14.7.1 Financial Analysis
14.7.2 Product Portfolio
14.7.3 Demographic Reach and Achievements
14.7.4 Mergers and Acquisitions
14.7.5 Certifications
14.8 Randox Laboratories Ltd.
14.8.1 Financial Analysis
14.8.2 Product Portfolio
14.8.3 Demographic Reach and Achievements
14.8.4 Mergers and Acquisitions
14.8.5 Certifications
14.9 R-Biopharm AG
14.9.1 Financial Analysis
14.9.2 Product Portfolio
14.9.3 Demographic Reach and Achievements
14.9.4 Mergers and Acquisitions
14.9.5 Certifications
14.10 Sysmex Corporation
14.10.1 Financial Analysis
14.10.2 Product Portfolio
14.10.3 Demographic
14.10.4 Mergers and Acquisitions
14.10.5 Certifications
14.11 Medline Industries LP
14.11.1 Financial Analysis
14.11.2 Product Portfolio
14.11.3 Demographic Reach and Achievements
14.11.4 Mergers and Acquisitions
14.11.5 Certifications
15 Latin America In-vitro Colorectal Cancer Screening Tests Market – Distribution Model (Additional Insight)
15.1 Overview
15.2 Potential Distributors
15.3 Key Parameters for Distribution Partner Assessment
16 Key Opinion Leaders (KOL) Insights (Additional Insight)
17 Company Competitiveness Analysis (Additional Insight)
17.1 Very Small Companies
17.2 Small Companies
17.3 Mid-Sized Companies
17.4 Large Companies
17.5 Very Large Companies
18 Payment Methods (Additional Insight)
18.1 Government Funded
18.2 Private Insurance
18.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us